# IDARUBICIN HYDROCHLORIDE
> **ANDA065037** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PARENTERAL · Approved 2002-05-01
## Drug
- **FDA Application Number:** ANDA065037
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** IDARUBICIN HYDROCHLORIDE
- **Generic name:** Idarubicin Hydrochloride
- **Active ingredients:** IDARUBICIN HYDROCHLORIDE
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** TEVA PARENTERAL
- **First approval:** 2002-05-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065037)
---
*AI Analytics · CC0 1.0*